Avoid This Critical Re-Consent Mistake in Clinical Trials

Protocol amendments are a routine part of clinical research, but neglecting re-consent procedures can lead to serious compliance issues. When a protocol changes, informed consent documents must be updated, and patients must sign the revised form at their next visit. Relying on memory or waiting for a monitor's reminder often results in protocol deviations that jeopardize trial integrity and invite scrutiny during FDA audits. Clinical research coordinators should prioritize timely re-consent to maintain accurate records and avoid findings that could derail a study.